With increasing specialty drug costs, pharmacy benefit managers,health plans and industry experts often tout the use of biosimilarsas a strategy to lower cost. In 2013,

As you may recall, back in March of this year, Eli Lilly announced that they would begin to manufacture and sell an authorized generic version

The news that the FDA approved the first A-rated (meaning that pharmacists may freely substitute it without physician approval) generic form of Advair Diskus on

Recently there has been much talk in the news about a seeming new class of drugs known as “biosimilars,” along with their purported ability to

In most cases, flu vaccines are covered under both the pharmacy and medical benefit plans. This is a good thing, as more options for access

The FDA has released a welcome new policy guidance document surrounding compounded drugs that will equip PBMs and Carriers with some much needed objective standards